Prospective Associations of Obesity and Obesity Severity With 9 Cardiovascular Outcomes: The Cross-Cohort Collaboration

Z Zeina A. Dardari (Johns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, Baltimore, MD (Z.A.D., Z.Y., Y.J., S.B., K.M., M.J.B.).) Z Zhiqi Yao J Jianjun Zhang G Giorgos Bakoyannis (Department of Epidemiology, Richard M. Fairbanks School of Public Health, Indiana University Indianapolis, IN (Z.A.D., J.Z., G.B., H.N., L.K.S.).) H Hongmei Nan (Department of Epidemiology, Richard M. Fairbanks School of Public Health, Indiana University Indianapolis, IN (Z.A.D., J.Z., G.B., H.N., L.K.S.).) L Lisa K. Staten (Department of Epidemiology, Richard M. Fairbanks School of Public Health, Indiana University Indianapolis, IN (Z.A.D., J.Z., G.B., H.N., L.K.S.).) K Kunal K. Jha (Division of Chemistry and Chemical Engineering) E Erfan Tasdighi (Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ (E.T.).) Y Yara Jelwan (Johns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, Baltimore, MD (Z.A.D., Z.Y., Y.J., S.B., K.M., M.J.B.).) S Semenawit Burka (Johns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, Baltimore, MD (Z.A.D., Z.Y., Y.J., S.B., K.M., M.J.B.).) K Kunihiro Matsushita (Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (K.M.).) E Eleanor M. Simonsick J Joao A.C. Lima (Department of Medicine, Division of Cardiology, Johns Hopkins School of Medicine, Baltimore, MD (J.A.C.L., W.S.P.).) B Bruce M. Psaty D Debbie L. Cohen (Division of Renal-Electrolyte and Hypertension, Department of Medicine, University of Pennsylvania, Philadelphia) L Lawrence J. Appel A Amit Khera A Amil M. Shah M Michael E. Hall (Department of Medicine, University of Mississippi Medical Center, Jackson, MS (M.E.H.).) S Suzanne E. Judd S Shelley A. Cole (Population Health Program, Texas Biomedical Research Institute, San Antonio, TX (S.A.C.).) R Ramachandran S. Vasan (Framingham Heart Study, National Heart, Lung, and Blood Institute, National Institutes of Health and Boston University, Framingham, MA, USA.) E Emelia J. Benjamin P Peggy M. Cawthon E Eric Orwoll (Division of Endocrinology, Diabetes and Clinical Nutrition, School of Medicine, Oregon Health & Science University, Portland, OR (E.O.).) M Michael J. LaMonte (Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY (M.J.L.).) C Charles B. Eaton S Samar R. El Khoudary (University of Pittsburgh School of Public Health, Department of Epidemiology, Pittsburgh, PA (S.R.E.).) R Rebecca C. Thurston (Departments of Psychiatry, University of Pittsburgh School of Medicine, PA (R.C.T.).) C Carol A. Derby (Departments of Neurology and Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY (C.A.D.).) P Paulo A. Lotufo I Isabela M. Bensenor M Márcio Sommer Bittencourt (Center for Clinical and Epidemiologic Research, Hospital Universitario, University of Sao Paulo, Sao Paulo, Brazil (P.A.L., I.M.B., M.S.B.)) M Michael J. Blaha

Abstract

BACKGROUND: Obesity is an established risk factor for cardiovascular disease (CVD); however, the overall and sex-specific relationships across the full spectrum of body mass index (BMI), particularly severe obesity defined as class 2 (BMI 35 to <40.0 kg/m 2 ) and class 3 (BMI ≥40 kg/m 2 ), and long-term CVD outcomes remain incompletely described. METHODS: We included 289 875 participants (mean age, 60.3 years; 79.2% women) from 21 cohorts of the Cross-Cohort Collaboration enrolled between 1948 and 2015 with harmonized BMI data, a BMI ≥18.5 kg/m 2 , and at least one of nine adjudicated outcomes: time to first fatal and non-fatal myocardial infarction (MI), fatal and nonfatal stroke, heart failure (HF), atrial fibrillation (AF), total coronary heart disease (CHD), total CVD, CHD mortality, CVD mortality, and all-cause mortality. Multivariable Cox proportional hazard models with restricted cubic splines were used to estimate the hazard ratio (HR) of BMI for each outcome, adjusting for demographic and clinical risk factors. RESULTS: Over 19.2 median years (25th, 11.6; 75th, 23.5 percentile) of follow-up, there were a total of 15 542 incident MI events, 15 467 incident stroke events, 14 172 incident HF events, 9066 diagnosed AF, and 113 918 total deaths, of which 14 647 were CHD-related and 28 879 were CVD-related. Overall, compared with individuals with normal weight, those with class 2 and class 3 obesity had the highest risk of HF (HR, 2.1, 95% CI, 2.0–2.3, and HR, 3.0, 95% CI, 2.7–3.2, respectively) and AF (HR, 1.8, 95% CI 1.7–2.0, and HR, 2.8, 95% CI, 2.5–3.1, respectively). Compared with men, women experienced higher relative increases in the risk associated with severe obesity for outcomes stroke, CVD, and all-cause mortality (P for interaction: <0.001, 0.003, and <0.001, respectively). Furthermore, in men, no increase in stroke risk was observed with higher BMI categories (P trend=0.49), whereas in women, the risk of stroke plateaued across obesity subclasses (compared with normal weight) yet remained significantly increased. CONCLUSIONS: Higher BMI was robustly associated with increased risk for most outcomes, particularly HF and AF, even after adjusting for traditional risk factors. Observed sex differences in the relative hazard of higher BMI categories and stroke, total CVD, and all-cause mortality suggest potential differences in underlying biological mechanisms.

Article Details

Journal Circulation
Volume / Issue Vol. 153, Issue 10
Published March 10, 2026
Pages 720-735
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (34)

Z

Zeina A. Dardari

Johns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, Baltimore, MD (Z.A.D., Z.Y., Y.J., S.B., K.M., M.J.B.).

Z

Zhiqi Yao

J

Jianjun Zhang

G

Giorgos Bakoyannis

Department of Epidemiology, Richard M. Fairbanks School of Public Health, Indiana University Indianapolis, IN (Z.A.D., J.Z., G.B., H.N., L.K.S.).

H

Hongmei Nan

Department of Epidemiology, Richard M. Fairbanks School of Public Health, Indiana University Indianapolis, IN (Z.A.D., J.Z., G.B., H.N., L.K.S.).

L

Lisa K. Staten

Department of Epidemiology, Richard M. Fairbanks School of Public Health, Indiana University Indianapolis, IN (Z.A.D., J.Z., G.B., H.N., L.K.S.).

K

Kunal K. Jha

Division of Chemistry and Chemical Engineering

E

Erfan Tasdighi

Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ (E.T.).

Y

Yara Jelwan

Johns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, Baltimore, MD (Z.A.D., Z.Y., Y.J., S.B., K.M., M.J.B.).

S

Semenawit Burka

Johns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, Baltimore, MD (Z.A.D., Z.Y., Y.J., S.B., K.M., M.J.B.).

K

Kunihiro Matsushita

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (K.M.).

E

Eleanor M. Simonsick

J

Joao A.C. Lima

Department of Medicine, Division of Cardiology, Johns Hopkins School of Medicine, Baltimore, MD (J.A.C.L., W.S.P.).

B

Bruce M. Psaty

D

Debbie L. Cohen

Division of Renal-Electrolyte and Hypertension, Department of Medicine, University of Pennsylvania, Philadelphia

L

Lawrence J. Appel

A

Amit Khera

A

Amil M. Shah

M

Michael E. Hall

Department of Medicine, University of Mississippi Medical Center, Jackson, MS (M.E.H.).

S

Suzanne E. Judd

S

Shelley A. Cole

Population Health Program, Texas Biomedical Research Institute, San Antonio, TX (S.A.C.).

R

Ramachandran S. Vasan

Framingham Heart Study, National Heart, Lung, and Blood Institute, National Institutes of Health and Boston University, Framingham, MA, USA.

E

Emelia J. Benjamin

P

Peggy M. Cawthon

E

Eric Orwoll

Division of Endocrinology, Diabetes and Clinical Nutrition, School of Medicine, Oregon Health & Science University, Portland, OR (E.O.).

M

Michael J. LaMonte

Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY (M.J.L.).

C

Charles B. Eaton

S

Samar R. El Khoudary

University of Pittsburgh School of Public Health, Department of Epidemiology, Pittsburgh, PA (S.R.E.).

R

Rebecca C. Thurston

Departments of Psychiatry, University of Pittsburgh School of Medicine, PA (R.C.T.).

C

Carol A. Derby

Departments of Neurology and Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY (C.A.D.).

P

Paulo A. Lotufo

I

Isabela M. Bensenor

M

Márcio Sommer Bittencourt

Center for Clinical and Epidemiologic Research, Hospital Universitario, University of Sao Paulo, Sao Paulo, Brazil (P.A.L., I.M.B., M.S.B.)

M

Michael J. Blaha